Andrew Hirsch - President & CEO, Director at C4 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
CCCC on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Hirsch since 7/7/2023

Holdings reported by Andrew Hirsch for C4 Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 210,741 $1.66 M $7.90 Feb 15, 2024 Direct
Stock Option (Right to Buy) 465,500 Feb 14, 2024 Direct Common Stock
Performance Restricted Stock Units 55,000 Aug 30, 2023 Direct Common Stock

Transactions reported by Andrew Hirsch for C4 Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership